trending Market Intelligence /marketintelligence/en/news-insights/trending/7n2m4nefohfwwkzjphjzha2 content esgSubNav
In This List

Dipexium Pharmaceuticals names chief medical officer

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Dipexium Pharmaceuticals names chief medical officer

New York-based drugmaker Dipexium Pharmaceuticals Inc. appointed Efthymios Deliargyris as chief medical officer.

Deliargyris was previously the chief medical adviser of the company.

Dipexium Pharmaceuticals is a late-stage pharmaceutical company, engaging in the development and marketing of antibiotics in the U.S.